Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0071 | 0.4172 | 0.415 |
Echinococcus multilocularis | muscleblind protein | 0.0146 | 1 | 1 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0036 | 0.1461 | 0.1461 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0023 | 0.0417 | 0.116 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0064 | 0.3597 | 0.3187 |
Onchocerca volvulus | Huntingtin homolog | 0.0127 | 0.847 | 0.5 |
Echinococcus multilocularis | tar DNA binding protein | 0.0064 | 0.3597 | 0.3597 |
Mycobacterium leprae | PROBABLE BACTERIOFERRITIN BFRA | 0.0017 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | bacterioferritin/cytochrome b1 | 0.0017 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.1835 | 0.1805 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0064 | 0.3597 | 0.3573 |
Brugia malayi | TAR-binding protein | 0.0064 | 0.3597 | 0.3187 |
Schistosoma mansoni | zinc finger protein | 0.002 | 0.0186 | 0.0517 |
Echinococcus granulosus | tar DNA binding protein | 0.0064 | 0.3597 | 0.3597 |
Echinococcus granulosus | zinc finger protein | 0.002 | 0.0186 | 0.0186 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.1651 | 0.162 |
Mycobacterium tuberculosis | Bacterioferritin BfrB | 0.0017 | 0 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.0064 | 0.3597 | 0.3573 |
Trichomonas vaginalis | ferritin, putative | 0.0017 | 0 | 0.5 |
Onchocerca volvulus | Huntingtin homolog | 0.0127 | 0.847 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0021 | 0.0268 | 0.0746 |
Mycobacterium ulcerans | bacterioferritin BfrA | 0.0017 | 0 | 0.5 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0023 | 0.0417 | 0.0417 |
Treponema pallidum | bacterioferrin (TpF1) | 0.0017 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0146 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.1984 | 0.1954 |
Brugia malayi | RNA binding protein | 0.0064 | 0.3597 | 0.3187 |
Schistosoma mansoni | bromodomain containing protein | 0.0064 | 0.3592 | 0.9986 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.3597 | 1 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0146 | 1 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0123 | 0.822 | 0.8106 |
Echinococcus granulosus | muscleblind protein | 0.0146 | 1 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0123 | 0.822 | 0.8213 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.3597 | 1 |
Brugia malayi | Bromodomain containing protein | 0.0039 | 0.1645 | 0.111 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0036 | 0.1461 | 0.1461 |
Mycobacterium tuberculosis | Probable bacterioferritin BfrA | 0.0017 | 0 | 0.5 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0021 | 0.0268 | 0.0232 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.3597 | 1 |
Brugia malayi | hypothetical protein | 0.0127 | 0.847 | 0.8372 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0123 | 0.822 | 0.8213 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.3597 | 1 |
Echinococcus multilocularis | zinc finger protein | 0.002 | 0.0186 | 0.0186 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.006 | 0.3313 | 0.3313 |
Loa Loa (eye worm) | hypothetical protein | 0.0127 | 0.847 | 0.8464 |
Mycobacterium ulcerans | bacterioferritin BfrB | 0.0017 | 0 | 0.5 |
Loa Loa (eye worm) | TAR-binding protein | 0.0064 | 0.3597 | 0.3573 |
Brugia malayi | Bromodomain containing protein | 0.0075 | 0.4506 | 0.4154 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0023 | 0.0417 | 0.0417 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.006 | 0.3313 | 0.3313 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.3597 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0146 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0127 | 0.847 | 0.8464 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.